The unique physicochemical properties
of gold nanoparticles (AuNPs)
provide many opportunities to develop novel biomedical technologies.
The surface chemistry of AuNPs can be engineered to perform a variety
of functions, including targeted binding, cellular uptake, or stealthlike
properties through the immobilization of biomolecules, such as proteins.
It is well established that proteins can spontaneously adsorb onto
AuNPs, to form a stable and functional bioconjugate; however, the
protein–AuNP interaction may result in the formation of less
desirable protein–AuNP aggregates. Therefore, it is imperative
to investigate the protein–AuNP interaction and elucidate the
mechanism by which protein triggers AuNP aggregation. Herein, we systematically
investigated the interaction of immunoglobulin G (IgG) antibody with
citrate-capped AuNPs as a function of solution pH. We found that the
addition of antibody triggers the aggregation of AuNPs for pH <
7.5, whereas a monolayer of antibody adsorbs onto the AuNP to form
a stable bioconjugate when the antibody is added to AuNPs at pH ≥
7.5. Our data identifies electrostatic bridging between the antibody
and the negatively charged AuNPs as the mechanism by which aggregation
occurs and rules out protein unfolding and surface charge depletion
as potential causes. Furthermore, we found that the electrostatic
bridging of AuNPs is reversible within the first few hours of interaction,
but the protein–AuNP interactions strengthen over 24 h, after
which the protein–AuNP aggregate is irreversibly formed. From
this data, we developed a straightforward approach to acrylate the
basic residues on the antibody to prevent protein-induced aggregation
of AuNP over a wide pH range. The results of this study provide additional
insight into antibody–nanoparticle interactions and provide
a pathway to control the interaction with the potential to enhance
the conjugate function.